FIELD: medicine.
SUBSTANCE: invention is related to medicine, oncology, and may be used for antitumor immunotherapy of patients with solid tumors. For this purpose after session of photodynamic therapy of primary tumor or its metastases, autologous bone-marrow precursors of dendrite cells in dose of 3×106 cells/kg of patient weight in 3.5 ml of officinal physiological solution for injections and 1.0 ml of human albumin. Introduction is executed into points intratumorally and along periphery of PDT-modified tumor, also along periphery of affected inguinal lymph nodes and interdigital space of foot or hand by 0.5 ml. The first five introductions are done every day. Then further five introductions are done every three weeks in 2-3 courses.
EFFECT: method makes it possible to activate specific antitumor immunity.
2 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOTHERAPY METHOD FOR TREATING PATIENTS FOR SOLID TUMORS BY APPLYING TUMOR LYSATE WITH BETALEUKINE ADJUVANT | 2004 |
|
RU2267326C2 |
METHOD FOR TREATMENT OF PRIMARY PATIENTS WITH LOCALLY ADVANCED CERVICAL CANCER | 2015 |
|
RU2616531C1 |
METHOD FOR IMMUNOTHERAPY OF CEREBRAL MALIGNANT TUMORS | 2004 |
|
RU2262941C2 |
IMMUNOTHERAPY OF BREAST CANCER USING ANTIGEN-ACTIVATED DENDRITIC CELLS | 2016 |
|
RU2645464C1 |
METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
HUMAN MELANOMA CELL LINE 26G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395571C1 |
HUMAN MELANOMA CELL LINE 31G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395573C1 |
HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
HUMAN MELANOMA CELL LINE IG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395572C1 |
HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
Authors
Dates
2009-12-20—Published
2008-04-17—Filed